Doctor Giuseppe Armentaro

Doctor Giuseppe Armentaro

Magna Graecia University of Catanzaro, Catanzaro (Italy)

Member of:

Giuseppe Armentaro born in Saronno (VA),Lombardia, Italy in 26/05/1991. He obtained his master's degree from the School of Medicine, University of Magnae Graecia of Catanzaro (Calabria, Italy) in 26/07/2017, and obtained his abilitation to clinical practice in 05/03/2018. He is currently a specialist in geriatrics at the Operative Unit of Geriatrics at the Renato Dulbecco Hospital - 'Magna Graecia' University of Catanzaro under the supervision of Prof. Angela Sciacqua. Area of interest: Heart Failure, Arterial hypertension, Atrial fibrillation, type 2 diabetes mellitus, COPD.

Presentations

Effect of oral semaglutide on global longitudinal strain and global myocardial work efficiency in patients with HFpEF, uncontrolled type 2 diabetes mellitus and obesity.

Event: Heart Failure 2024

Topic: Comorbidities

Session: Chronic heart failure - comorbidities 2

Access

Prognostic role of serum albumin levels in patients with chronic heart failure.

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Acute heart failure - epidemiology, prognosis, outcome 2

Access

Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.

Event: Heart Failure 2024

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure - pathophysiology and mechanisms 2

Access

Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Cardiovascular Disease in the Elderly

Session: Heart disease in the elderly: treatment and outcomes

Access

Effect of semaglutide on global longitudinal strain and global myocardial work efficiency in patients with uncontrolled type 2 diabetes mellitus and obesity.

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Diabetes and the heart (3)

Access

Short term effect of sodium glucose cotransporter 2 inhibitors and sacubitril/valsartan on comprehensive geriatric assessment and oxidative stress in elderly with chronic heart failure (from MAGIC-HF)

Event: ESC Congress 2023

Topic: Comorbidities

Session: Comorbidities and heart failure: cause and effect

Access

Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Neprilysin inhibition: news and nuggets

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Giuseppe Armentaro

Biography

Contributor content

Effect of oral semaglutide on global longitudinal strain and global myocardial work efficiency in patients with HFpEF, uncontrolled type 2 diabetes mellitus and obesity.

Prognostic role of serum albumin levels in patients with chronic heart failure.

Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.

Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Effect of semaglutide on global longitudinal strain and global myocardial work efficiency in patients with uncontrolled type 2 diabetes mellitus and obesity.

Short term effect of sodium glucose cotransporter 2 inhibitors and sacubitril/valsartan on comprehensive geriatric assessment and oxidative stress in elderly with chronic heart failure (from MAGIC-HF)

Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea

ESC 365 is supported by

Doctor Giuseppe Armentaro Follow

Biography

Contributor content

Effect of oral semaglutide on global longitudinal strain and global myocardial work efficiency in patients with HFpEF, uncontrolled type 2 diabetes mellitus and obesity.

Prognostic role of serum albumin levels in patients with chronic heart failure.

Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.

Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Effect of semaglutide on global longitudinal strain and global myocardial work efficiency in patients with uncontrolled type 2 diabetes mellitus and obesity.

Short term effect of sodium glucose cotransporter 2 inhibitors and sacubitril/valsartan on comprehensive geriatric assessment and oxidative stress in elderly with chronic heart failure (from MAGIC-HF)

Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea

ESC 365 is supported by

Doctor Giuseppe Armentaro